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The Mongolian gerbil, Meriones unguiculatus, has been widely employed as a model for studies of the
inner ear. In spite of its established use for auditory research, no robust protocols to induce ototoxic hair
cell damage have been developed for this species. In this paper, we demonstrate the development of an
aminoglycoside-induced model of hair cell loss, using kanamycin potentiated by the loop diuretic
furosemide. Interestingly, we show that the gerbil is relatively insensitive to gentamicin compared to
kanamycin, and that bumetanide is ineffective in potentiating the ototoxicity of the drug.
We also examine the pathology of the spiral ganglion after chronic, long-term hair cell damage.
Remarkably, there is little or no neuronal loss following the ototoxic insult, even at 8 months post-
damage. This is similar to the situation often seen in the human, where functioning neurons can
persist even decades after hair cell loss, contrasting with the rapid, secondary degeneration found in rats,
mice and other small mammals. We propose that the combination of these factors makes the gerbil a
good model for ototoxic damage by induced hair cell loss.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Since their introduction in the 1940s, aminoglycoside antibiotics
have been recognised clinically for their off-target effects of
ototoxicity. When used in combination therapy with a loop diuretic
such as ethacrynic acid, the often-reversible deafness seenwith the
antibiotic alone was rapidly induced and permanent (Brown et al.,
1974; Mathog et al., 1969). Such damage was found to be caused by
the death of the sensory cells of the specialised hearing epithelium,
the organ of Corti, located within the bony shell of the cochlea. The
destruction of the three rows of outer hair cells and single row of
inner hair cells would eventually lead to loss of the surrounding
supporting cells and the replacement of the organ with a ﬂattened
epithelium of scar tissue, and accompanying profound deafness inABR, Auditory Brainstem
iaminetetraacetic acid; PBS,
min; DAPI, 4,6-diamidino-2-
enzoate; ANOVA, Analysis of
ter hair cells; IHC, Inner hair
iology and Department of
urt, Western Bank, Shefﬁeld
114 222 2787.
ivolta).
r B.V. This is an open access articlethe patient. However, as the ﬁeld of regenerative medicine moves
forward, this damaged epithelium becomes a potential target for
therapeutic intervention, whether it be the idea of recreating the
organ of Corti, or in its role as a model for cochlear implantation
studies.
A sequela to the death of the organ of Corti is often the sec-
ondary loss of the spiral ganglion neurons (SGNs) which innervate
the hair cells. This loss occurs with varying rapidity in different
species. For instance in the guinea pig, a substantial abrogation of
SGNs is observed 7 days after aminoglycoside treatment (Kong
et al., 2010), whereas in human patients, remaining SGNs have
been found several decades after hair cell loss is thought to have
occurred (Ghorayer et al., 1980).
The gerbil is a well-established model for auditory research
given its particular hearing physiology (Otto and Jürgen, 2012). On
account of its ethology in the wild, the animal has a broad fre-
quency range of hearing e low frequencies are used when ‘drum-
ming’ with the hind limbs as a warning communication; at the
other end of the auditory spectrum, animals ‘chirp’ at each other up
to a level of around 25 kHz. This overlap with the human hearing
range arguably makes the gerbil a more relevant model for hearing
loss than high-frequency specialists such as the mouse or rat.
Moreover, the species is surgically robust, with the relatively large
cochlea easily accessed through the thin bone of the auditory bullaunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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peutic strategies requiring cell or drug delivery.
Remarkably though, while reliable protocols have been devel-
oped for the neuropathic damage of the spiral ganglion (Lang et al.,
2005; Schmiedt et al., 2002), a simple and robust method to induce
ototoxic lesions of the hair cells is not available for this species.
Current protocols involve the topical application of aminoglyco-
sides using slow-releasing gels or repeated application of amino-
glycosides by transtympanic injections (Polgar et al., 2001;
Wanamaker et al., 1999). Both methods are invasive and, at least
in our hands, have proven unreliable.
Here we present data showing that the gerbil can be used as a
model for rapid and permanent aminoglycoside-induced hearing
loss using a ‘one-shot’ protocol, inwhich a single dose of kanamycin
is accompanied by a dose of the loop diuretic furosemide. This is a
reﬁnement of experiments carried out in other species, where
repeated, often toxic, dosage regimes have been employed.
2. Materials and methods
2.1. Animals
Mongolian gerbils from an in-house breeding colony (originally
sourced from Charles River, Germany) were raised and aged be-
tween 3 and 6 months at the beginning of the protocol e no effect
of age was noted on the initial hearing threshold measured. A
mixture of males and females were used e no difference between
sexes in hearing ability has been observed in our colony. All ex-
periments were carried out in accordance with the Shefﬁeld Uni-
versity Ethical Review Committee and under a Home Ofﬁce Project
Licence authority, conforming to UK and EU legislation.
2.2. Ototoxicity models
For systemic assays, animals were injected sub-cutaneously
with a solution of gentamicin sulphate or kanamycin sulphate in
normal saline (400e500 mg/kg; Sigma, Gillingham, U.K.) followed
20e30 min later by an intra-peritoneal injection of bumetanide
(50 mg/kg; Sigma) or furosemide solution (100 mg/kg; Sigma). For
topical application to the cochlea, anaesthesia was induced with
isoﬂurane, the auditory bulla was accessed through a retro-
auricular incision and windowed using a scalpel blade. Amino-
glycoside and diuretic solutions (as above) were applied directly to
the round window; in some cases, animals were implanted with a
gelatin sponge (Cutanplast, Shefﬁeld, U.K.) pre-soaked in an ami-
noglycoside/diuretic mixture. The bulla was sealed using a plug of
fascia held in place with Vetbond adhesive (3 M, Bracknell, U.K.).
The muscle layer and wound were closed with absorbable Vicryl
suture material (Ethicon, Norderstedt, Germany) and the animal
allowed to recover.
2.3. Auditory measurements
Animals were sedated with a ketamine/xylazine mix and placed
on a heat mat to maintain body temperature. The System 3 digital
signal processing package of hardware and software (Tucker Davies
Technologies (TDT), Florida) was used to present click stimuli
ranging from 110 dB to 20 dB at a rate of 20 s1 in decreasing 10 dB
steps. Tone stimuli were presented as pure tone pips lasting 5ms at
80 dB, at frequencies ranging from 6 kHz to 38 kHz in 4 kHz steps or
at 2 kHz, 4 kHz, 8 kHz, 16 kHZ and 32 kHz at an intensity ranging
from 20 dB to 90 dB. The sounds were presented to the animal via a
‘closed ﬁeld’ method e a 3 mm diameter, 10 cm tube leading from
the speaker was inserted into the auditory meatus until its tip was
close to the tympanic membrane. Auditory brainstem response(ABR) measurements were recorded using 27G subdermal needle
electrodes placed at the vertex of the skull (recording electrode)
and the ipsilateral mastoid process (reference electrode), with a
ground electrode placed dorsally adjacent to the tail. The differ-
ential voltage induced by the presentation of the sound stimulus
was thus recorded. Each stimulus was presented 500 times, thus
the wave generated represented an average response over this
time. For each intensity, the amplitude of the response between the
wave ii positive peak (P2) and the wave iii negative peak (N3),
representing the neural activity within the cochlear nucleus and
the superior olivary complex respectively, was measured, giving a
‘read-out’ of activity within the central auditory pathway (Burkard
et al., 1993; Boettcher et al., 2006). The click ABR threshold was
calculated as the sound level required to produce a voltage
response two standard deviations above the mean noise level for
each recording (May et al., 2002). All experiments were carried out
in a sound-proof, custom-made audiology booth (AGS Noise Con-
trol Ltd, Melton Mowbray, U.K.).
2.4. Immunohistochemistry
Temporal bones were ﬁxed by immersion in 4% para-
formaldehyde (PFA; pH 7.4) for 24e48 h at 4 C and decalciﬁed in
0.5 M ethylenediaminetetraacetic acid (EDTA) pH8 for a week at
4 C. Samples were taken through an ascending sucrose/PBS series
(7.5%, 15%, 22.5%, 30; several hours/overnight in each stage).
Following embedding in Cryo-M-Bed medium (VWR, Lutterworth,
U.K.), 12 mm sections were taken on a Bright cryostat onto gelatine/
chrome alum-coated glass slides. The tissue sections were defros-
ted, rehydrated and brieﬂy re-ﬁxed with 4% PFA, rinsed with 0.1%
Triton/PBS and blocked in 5% donkey serum/1% B.S.A. before incu-
bation overnight at 4 C with the following antibodies: anti-aTu-
bulin (1:150, mouse monoclonal; Sigma), anti-bIIIeTubulin (1:150,
mouse monoclonal; Sigma), anti-espin (1:100, rabbit polyclonal;
Sigma), anti-myelin basic protein (MBP; 1:75, mouse monoclonal;
Millipore), anti-MyoVIIA (1:100, rabbit polyclonal; kind gift, C.
Petit), anti-OCP2 (1:100, rabbit polyclonal, kind gift R. Thalmann),
anti-Neuroﬁlament 200 (NF-200; 1:200, rabbit polyclonal; Sigma),
anti-Na, K-ATPase a3 subunit (NKAa3; Santa Cruz, Insight
Biotechnology, Wembley, U.K.), anti-CtBP2 (BD Biosciences, Oxford,
U.K.). Detection was carried out by incubating for 2 h at room
temperature with anti-mouse Alexa 488 and anti-rabbit Alexa 568
(Life Technologies, Paisley, U.K.) and the tissue counter-stained
with 4,6-diamidino-2-phenylindole (DAPI) (Sigma) before
mounting in Vectashield (Vector Laboratories, Peterborough, U.K.).
Images were taken on a Zeiss Axiophot microscope using Axiovi-
sion software and ﬁgures assembled using Adobe Photoshop 7.0.
Whole-mount staining of intact cochleae was carried out essen-
tially as described in MacDonald and Rubel (2008). Brieﬂy, ﬁxed
cochleae were decalciﬁed as above, rinsed in PBS and incubated
with primary antibodies (anti-bIIIeTubulin and anti-MYOVIIA as
above) for several days with agitation at 4 C. After washing,
samples were incubated at 4 C with anti-mouse Alexa 488 and
anti-rabbit Alexa 568 for 3e5 days. After washing, samples were
dehydrated through an increasing ethanol gradient and cleared
through MSBB, in a 5:3 ratio of methyl salicylate and benzyl ben-
zoate (Sigma), for 2 days. Imaging was then carried out using a Zeiss
LSM510 inverted confocal microscope. Images were analysed using
FIJI (http://ﬁji.sc/Fiji) and ﬁgures assembled in Photoshop as above.
2.5. Phalloidin staining
Temporal bones were ﬁxed and decalciﬁed as described above.
Cochlear epithelia were dissected out and washed in 0.1% Triton/
PBS prior to incubation overnight in Alexa Fluor 568 phalloidin
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Triton/PBS, samples were mounted in Vectashield and imaged as
above.
2.6. Spiral ganglion density calculation
SGNs in Rosenthal's canal were stained for bIIIeTubulin and
counted from images taken on a Zeiss Axiophot microscope as
before. Apical, mid and basal turns were counted from a minimum
of ﬁve, mid-modiolar sections per cochlea. Sections counted were
at least 36 mm apart to prevent over-counting. Cell density was
calculated by measuring the area of Rosenthal's canal using FIJI
(http://ﬁji.sc/Fiji) and calculating the number of cells per mm2.
One-way ANOVA and unpaired t-tests for signiﬁcance were carried
out in Prism (Graphpad Software, San Diego, U.S.A.).
3. Results
3.1. Topical gentamicin application does not induce obvious
cochlear hair cell loss
Our ﬁrst investigations focussed on topical application of the
aminoglycoside to the cochlea. The auditory bulla was fenestrated
and 400 mg of gentamicin sulphate in aqueous solutionwas applied
to the round windowmembrane (RWM), either directly (n ¼ 3); or
on a pre-soaked piece of gelatin sponge to effect a ‘slow release’
(n ¼ 1). However, contrary to results seen in the guinea pig (Yang
et al., 2010) and previously in the gerbil (Sheppard et al., 2004)
there was no obvious loss of hair cells (Fig. 1). Immunoﬂuorescence
was performed on sectioned cochlear tissue e the markers for IHCs
and OHCs, MYO7A and ESPIN showed normal expression in treated
vs. untreated contralateral ears throughout the entire extent of the
cochlea (Fig. 1AeD vs. EeH and IeL vs. MeP), suggesting that no
damage had occurred on account of this treatment. Representative
sections from the basal (AeH) and mid (IeP) turns are shown in
Fig. 1; similar results were observed at all three axial levels for both
treatment paradigms. Innervation of the organ of Corti was assayed
with the neural marker b-III TUBULIN (Hallworth and Luduena,
2000) and no apparent loss of innervation to the inner hair cells
was noted after gentamicin treatment (see white arrowheads,
Fig. 1). These results were conﬁrmed at the functional level (Fig. 1Q,
R). ABR click thresholds stayed at 20 dB (data not shown), showing
no shift above the measured starting threshold and similar click
response proﬁles were observed up to 80 dB, with animals being
tested at regular intervals post-treatment. In the acute case shown
(Fig. 1Q), the procedure was terminated at 3 weeks post-
application, whereas the chronic application was allowed to run
for 11 weeks lest there be a slow degeneration e however, this was
clearly not the case, with the measured response amplitudes
remaining consistent. No behavioural phenotype indicative of
vestibular toxicity, such as circling or head bobbing, was noted in
these animals. These results, although involving a small cohort of
animals, suggested to us that the use of gentamicinwould not be an
appropriate choice as an efﬁcient ototoxic agent in this system and
consequently gentamicin was not pursued any further.
3.2. Combined application of kanamycin and bumetanide induces
only mild damage
Kanamycin has also been widely used as a means of inducing
cochlear ototoxicity in other animal models, such as the rat
(Astbury and Read, 1982) or the guinea pig (Aran et al., 1975;
Poirrier et al., 2010). However, studies have demonstrated that its
effects are strongly potentiated when used in conjunction with a
loop diuretic, such as ethacrynic acid (Brummett, 1981) orbumetanide (Taylor et al., 2008). In a pilot experiment, both drugs
were administered in a systemic treatment paradigm with a single
dose of kanamycin followed forty minutes later by a dose of
bumetanide, which clearly induced diuresis (n ¼ 1). Alternatively,
drugs were applied together on gelatine sponge topically to the
RWM as above (Section 3.1) (n ¼ 1). Again however, neither regime
generated an obvious loss of cochlear hair cells as shown by the
normal expression of ESPIN and MYO7A in the inner and outer hair
cells throughout the cochlea. Representative turns are shown in
Fig. 2AeH. Systemic treatment did not result in a loss of hearing
(Fig. 2I) e a robust response to a 20 dB click was preserved for the
nine week duration of the protocol. However, a slight decrement in
hearing was observed in the topical, gelatine sponge treatment
paradigm (Fig. 2JeL). The auditory threshold was raised from 20 dB
to 27 dB (Fig. 2K) over the course of the experiment and an analysis
of the responses to pure tone frequencies suggests that this loss
occurs predominantly in the mid-frequency range, with 18e34 kHz
beingmost affected (Fig. 2L). Albeit signiﬁcant, this loss is too subtle
for our purposes of inducing rapid and substantial hearing loss and
again, this dosing regimen was not pursued further.
3.3. Treating with kanamycin and furosemide gives substantial hair
cell loss
The loop diuretic furosemide has also been widely used to
strengthen the ototoxic effects of aminoglycosides e for examples,
see (Alam et al., 1998; Brummett et al., 1975; Hirose et al., 2011) and
references therein. In gerbils treated with a single dose of kana-
mycin only, no evidence of hair cell loss is observed (data not
shown). However, when a single, systemic kanamycin dose is fol-
lowed shortly afterwards with an injection of furosemide, there
follows a rapid and substantial loss of both inner and outer hair
cells (Fig. 3). Immunoﬂuorescence for the protein ESPIN shows a
complete loss of immunoreactivity one week after drug adminis-
tration (Fig. 3AeD), implying a loss of hair cell function e when
compared with untreated controls, there is an absence of staining
in the single row of inner hair cells and all three rows of outer hair
cells. Equivalent results are found when samples are stained for the
presence of MYO7A (data not shown). Phase contrast imaging
coupled with immunoﬂuorescence for the calcium binding protein
PARVALBUMIN at one week post-treatment conﬁrms these results
(Fig. S1), such that the PARVALBUMIN-positive inner hair cells are
lost at all levels of the cochlea, leaving behind PARVALBUMIN-
positive afferent ﬁbres projecting into the damaged organ of
Corti. Meanwhile, however, the tunnel of Corti is still present at this
stage and the architecture of the hearing organ appears to be
relatively intact (‘t’; Fig. 3A, D). As would be expected fromwork in
other mammalian species though, this hair bundle loss is perma-
nent. At later time points, for example at 16wk and 34wk post-
treatment, there is little to no immunoreactivity for espin and the
organ of Corti has degenerated, with a collapse of the tunnel of
Corti and a ﬂattening of the putative remaining support cells
(Fig. 3EeL). However, the presence of spiral ganglion neurons
afferent processes remains intact throughout (white arrowheads, A,
E, I), even eightmonths after the acute ototoxic insult and in spite of
the hair cell loss (see Section 3.4 for further investigation of this).
The auditory brainstem response (ABR) was measured in ﬁfteen
animals both prior to and at intervals subsequent to the ototoxic
challenge (Fig. 3M, N). As alluded to in Section 3.1, the ABR evoked
by a broad-spectrum click ranging from 20 dB to 110 dB was
recorded before the drug dosing, one week later (Fig. 3M) and at
frequent intervals until the end of the procedure (data not shown).
Auditory thresholds were raised on average by almost 69 dB after
one week (n ¼ 15, 24 ears; Fig. 3M) with rises in individual animals
ranging from 36 to 97 dB. At the end of the procedure there was an
Fig. 1. Topical application of gentamicin has no effect on the hearing organ. Gentamicin sulphate solution was applied directly to the round windowmembrane either acutely (EeH,
Q) or as in a ‘slow release’ paradigm on a gelatine sponge (MeP, R). Immunoﬂuorescence for b-III TUBULIN and the hair cell markers MYO7A (B, D, F, H) and ESPIN (J, L, N, P) show
that there is no effect on the organ of Corti in either situation e comparison with untreated contralateral ears (AeD; IeL) shows no overt difference in structure or integrity of the
inner and outer hair cells. Sections are counterstained with DAPI to delineate cell nuclei. There is no disruption to the innervation of the IHCs by spiral ganglion neurons (ar-
rowheads, A, E, I, M). Click ABR measurements were taken at intervals post-treatment e no difference in response was found down to 20 dB with either treatment regime (Q, R).
Arrows point to inner hair cells, brackets delineate the three rows of outer hair cells. Scale bar e 50 mm.
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shown). This is not signiﬁcantly different to the loss seen after one
week, with average measured thresholds being 94 dB and 93 dB
respectively implying that the majority of the damage seen occurs
as an acute response to the ototoxic insult. There was no difference
in the response between the left and right ears, with the average
threshold increase at oneweek post-insult being of 72 dB and 67 dB
respectively (Fig. 3M).
The responses to individual frequency pips from 2 kHz to 32 kHz
at an intensity range of 20 dBe90 dB were also measured (n ¼ 6
animals; 12 ears measured; Fig. 3N). A highly signiﬁcant rise in
threshold was observed across the frequency spectrum measured
(see Table 1), implying that the hair cells were equally sensitive to
the treatment along the length of the cochlea.3.4. Hair cell counts one week after kanamycin/furosemide
treatment
The damage to both inner and outer hair cells is substantial. To
quantify the degree of hair cell loss observed, a cohort of animalswas treated with kanamycin and furosemide and the cochleae
were examined one week later using whole-mount immunoﬂuo-
rescence (MacDonald et al., 2008), a technique which allows the
individual turns of the cochlea to be imaged in an ‘in situ’ context
(Fig. 4). Staining for MYO7A immunoreactivity and subsequent cell
counting analysis (Table 2) showed a massive loss of both inner
and outer hair cells, demonstrated by the loss of MYO7A staining,
at all levels of the cochlea (Fig. 4B, E, H, K, N, Q). A handful of IHCs
remain in the basal turn of the treated condition (Fig. 4Q), but
these are clearly dysmorphic compared to their untreated coun-
terparts (Fig. 4N) and may represent a dying population yet to be
cleared by macrophages. The position of the organ of Corti was
determined by the position of the underlying b-III TUBULIN
staining (Fig. 4A, D, G, J, M, P).3.5. Non-sensory cells retain their identity
There have been reports in the literature of the loss of support
cell identity as a secondary consequence of the loss of the sensory
hair cells e the support cells become ﬂattened and assume a
Fig. 2. Application of kanamycin and bumetanide has minor effects on hearing. A combinatorial approach using kanamycin and bumetanide has no effect when dosed systemically
(AeD, I), and only gives a moderate loss of hearing when given as a topical, chronic application (EeH, JeL). Immunoﬂuorescence for ESPIN shows that in both cases the organ of
Corti is intact (arrows and brackets B, F, compare with untreated control, Fig. 1J, L) and b-III TUBULIN staining shows that the innervation to the hair cells is normal (arrowheads, A,
E). Sections are counterstained with DAPI to delineate cell nuclei. Typical sections from each sample are shown e apical turn (AeD), basal turn (EeH). Click ABR responses are
maintained at 20 dB in the systemic treatment (I). There is a minor increase in auditory threshold in the topical case 6wk after treatment (J, K), and this functional decrement is most
pronounced in the mid-frequency range, from 18 to 30 kHz (L). Arrows point to inner hair cells, brackets delineate the three rows of outer hair cells. Scale bar e 50 mm.
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2011; Huizing et al., 1987; Taylor et al., 2012). To examine this in
the kanamycin/furosemide treated gerbil, sections of the cochlea
taken at the various time points were examined for their expression
of OCP2, a component of the SCF ubiquitin ligase complex (Henzl
et al., 2004), which is abundant in the non-sensory cochlea cells,
from the interdental cells of the spiral limbus to the root cells of the
spiral ligament; and acetylated aTUBULIN, a marker for Deiter's
cells and inner and outer pillar cells (Saha et al., 2000; Tannenbaum
et al., 1997). Expression levels of OCP2 remained comparable to the
untreated condition at all stages post-insult, from 1 week to
34weeks (Fig. 5AeL). Similarly, levels of acetylated aTUBULIN
remained equivalent in untreated vs. treated animals (Fig. 5MeX),
in the pillar cells and Deiter's cells. Although we have not per-
formed a quantitative analysis of the expression of these markers to
categorically conﬁrm they remained unchanged, their qualitative
visualization would suggest that the support cells are capable of
surviving for long periods in the absence of hair cells in the gerbil.
The tunnel of Corti remained open and intact for a considerabletime post-damage (16wk, data not shown; 22wk Fig. 5GeI, aster-
isks) and classical support cell morphology was maintained, similar
to that seen when compared with untreated (Fig. 5AeC) and early
lesioned animals (1wk, Fig. 5DeF). However, after long-term
damage, a change in cell morphology was in evidence e samples
at 34wk displayed a collapse of the tunnel of Corti (arrows,
Fig. 5JeL) and a clear ﬂattening of the pillar cells.
3.6. Peripheral neural processes into the damaged organ of Corti
remain intact
The inner and outer hair cells degenerate in response to the
ototoxic insult (Figs. 3 and 4, S1, S2). However, it would appear that
substantial innervation is maintained in the organ of Corti (Figs. 3,
4, 6 and 7, S1, S2). It has been suggested by previous workers
(Stankovic et al., 2004; Sugawara et al., 2005; Zilberstein et al.,
2012) that spiral ganglion neurons may still be receiving trophic
support from surviving support cells in the organ of Corti e this
may well indeed be the case, but interestingly the ‘knot’ of distal
Fig. 3. Systemic application of kanamycin and furosemide destroys inner and outer hair cells. Systemic application of kanamycin and furosemide gives a rapid and comprehensive
destruction of both inner and outer hair cells. Immunoﬂuorescence for the hair bundle marker ESPIN shows a complete loss of immunoreactivity 1wk after drug administration,
implying a loss of hair cell function (compare arrows and brackets in B with the control situation in Fig. 1J). The tunnel of Corti is present at this stage (t, A, D). The hair bundle loss is
permanent e at both 16wk and 34wk post-treatment, there is no restoration of the hair bundle (arrows and brackets, F, J) and the organ of Corti has degenerated e asterisks in F, H
point to a small area of anomalous espin expression which would not constitute a functioning hair cell and may represent a hair cell in the process of being engulfed and destroyed.
However, the presence of the spiral ganglion neuron processes remains intact (arrowheads, A, E, I.) DAPI is used as a counterstain as previously. Average click ABR thresholds rise
considerably after treatment (M), from around 27 dB initially to around 97 dB after seven days. No difference is seen between the responses of the left and right ears (left ear n ¼ 9;
****p < 0.0001; right ear n ¼ 15; ****p < 0.0001). Pure tone ABR threshold measurements one week after kanamycin/furosemide treatment demonstrate an equivalent loss of
response across the frequency range measured, 2e32 kHz (N) (n ¼ 6; ****p < 0.0001). Mean and SEM plotted throughout. Scale bar e 50 mm.
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organ appears to have been replaced by characteristic ‘damage’
epithelium (Fig. 3I, L).
3.7. Most spiral ganglion neurons are preserved after hair cell death
To see how this gerbil model of ototoxicity compares with other
mammals, an investigation into spiral ganglion neuron density was
carried out at varying time points after treatment. It was found that
there is little loss of spiral ganglion neuron cell bodies in Rosen-
thal's canal, even up to 8 months post-treatment, in animals where
hearing loss had been conﬁrmed by the increase in click ABR
threshold one week after the kanamycin/furosemide treatment
(Fig. 6). Representative sections were assayed from the apical, midTable 1
Measuring the ABR resulting from a range of individual tone frequencies shows a signiﬁ
Frequency (kHz) Average threshold before K/F (dB SPL) Average t
2 29 87
4 26 85
8 53 88
16 58 82
32 65 87and basal turns of the cochlea e in all cases, loss of hair cells was
conﬁrmed by the absence of co-labelling with the hair-cell speciﬁc
markers ESPIN (Fig. 6) or MYOSIN7A (data not shown). As
mentioned above, the axons innervating the organ of Corti remain
in situ in the absence of the hair cells (denoted by white arrow-
heads in Fig. 6A, E, I, M) and do not die back. Average spiral ganglion
cell numbers per unit area (mm2) were calculated in untreated,
control animals (n ¼ 5) and in cohorts of 1wk (n ¼ 3); 10e20wk
(n¼ 5) and 20wkþ (n¼ 4) post-treatment e see Tables 3 and 4 and
Fig. 6. Cell numbers in the untreated condition were concordant
with previously published data for gerbils of a similar age (Chen
et al., 2012). A preliminary analysis of the data (Table 3,
Fig. 6QeS) shows that average SGN numbers are not reduced in the
treated animals in the apical and basal turns, but that there is amildcant increase in auditory threshold across a broad frequency spectrum.
hreshold after K/F (dB SPL) D Threshold (dB SPL) Signiﬁcant?
58 Yes****
59 Yes****
35 Yes****
24 Yes****
22 Yes****
Fig. 4. Quantiﬁcation of hair cell loss at all three cochlear levels. Whole-mount immunostaining of the cochlea with antibodies directed towards bIII-TUBULIN as a marker for spiral
ganglion neurons (A, D, G, J, M, P and merged panels C, F, I, L, O, R) and MYO7A (B, E, H, K, N, Q and merged panels) to show the hair cells demonstrates a marked and quantiﬁable
loss of both IHCs and OHCs at one week after kanamycin/furosemide treatment (DeF, JeL, PeR) when compared with untreated controls (AeC, GeI, MeO). Apical (AeF) mid (GeL)
and basal (MeR) turns have an equivalent loss of OHCs, whereas there is a handful of IHCs remaining basally (arrows, Q) e however, these cells have lost their elongated
morphology and are likely to represent a dying population. Cell counts were carried out and the mean number of each cell type per turn is displayed graphically in S, T; error bars
represent SEM Scale bar e 25 mm throughout AeR.
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Table 2
IHC and OHC counts from untreated and kanamycin/furosemide treated animals after 1 wk. ‘n’ refers to the number of cochleae counted per condition and come from 2
(untreated condition) or 3 (treated condition) different animals. There is a signiﬁcant loss of hair cells at each turn of the cochlea.
Apical Mid Basal
Cells/mm2 n p < 0.05 Cells/mm2 n p < 0.05 Cells/mm2 n p < 0.05
Untreated IHCS 113.8 2 99.8 2 103.9 2
Treated IHCs 0 5 Yes**** 21.6 5 Yes* 19.7 3 Yes*
Untreated OHCs 457.8 2 393.3 2 402.5 2
Treated OHCs 0 5 Yes**** 1.8 5 Yes**** 0 3 Yes***
L. Abbas, M.N. Rivolta / Hearing Research 325 (2015) 12e26 19reduction in cell number in the mid turn of the cochlea e the mean
number of SGNs is reduced to an average of 1857/mm2 compared to
2106/mm2 in the control condition, a loss of approx. 12%. However,
this is a minor loss compared to the large scale and rapid degen-
eration found in the guinea pig, for example (Bae et al., 2008) e an
examination of the ﬂuorescent micrographs gave a visualFig. 5. Expression of the markers OCP2 and aTUBULIN in drug treated animals. The protein
organ of Corti. Their expression remains high in the cochlea at all stages post-treatment w
(AeC) at 1wk (DeF), 22wk (GeI) and 34wk (JeL), suggesting that the damaged epithelium r
34wk (JeL). Asterisks in A, C, D, F, G, I mark the intact tunnel of Corti; arrows in J, L indicate w
similar proﬁle. In the untreated condition (MeP), the inner hair cells are clearly visible (arr
support cells, marked by aTUBULIN, remain intact and differentiated (arrows, M, P, Q, T, U, X)
Q, T, U, X). DAPI is used as a nuclear counter-stain. Scale bar e 50 mm throughout.conﬁrmation that there still remained a considerable number of
SGNs, even at 34wk post-treatment (compare panels A, D with M,P,
Fig. 6). Further analysis of the average SGN numbers remaining at
particular timepoints clariﬁed this loss (Table 4, Fig. 6TeV), con-
ﬁrming that it was indeed restricted to the mid turn of the cochlea
and moreover, only occurred a substantial time after the ototoxics OCP2 and acetylated aTUBULIN are markers for non-sensory supporting cells in the
ith kanamycin/furosemide. OCP2 levels are comparable with the untreated condition
etains some level of differentiation, although it has become ﬂattened in appearance by
here this structure has collapsed. Costaining of MYO7A with aTUBULIN (MeX) shows a
owheads, N, P) e this staining is lost at all stages post-treatment as before (QeX). The
and the tunnel of Corti remains open (QeX) up to 22wk post-treatment (asterisks, M, P,
Fig. 6. SGNs are preserved well after long-term kanamycin/furosemide-induced ototoxicity. SGNs residing in Rosenthal's canal were stained for the marker b-III TUBULIN and
counted in untreated (A, D) and treated animals (E, H, I, L, M, P) at various time points post drug treatment. In all treated cases, immunostaining with the marker ESPIN dem-
onstrates a loss of both inner (arrows e F, J, N) and outer hair cells (brackets e F, J, N) compared to the untreated situation (B); however in all cases, b-III TUBULIN staining suggests
that innervation to the degenerating organ of Corti is maintained (arrowheads, E, I, M) as before (Fig. 3). There is no signiﬁcant difference in the remaining number of SGNs at apical
and basal levels of the cochlea, with a signiﬁcant but mild loss in the mid-turn. (QeS; **p < 0.05). A breakdown of the SGN counts between different groups at the different time
points (TeV) demonstrates that the extent of SGN loss in the mid-turn occurs at 10e20wk post-treatment, becoming slightly worse at 20wkþ (U). Mean and SEM are plotted.
Representative images for mid-apical turns are shown for each condition, with DAPI used as a nuclear counterstain. Scale bar e 100 mm, panels AeP.
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Fig. 7. Sensory afferent neural processes remain into the organ of Corti in the absence of inner hair cells. Untreated (AeD, IeL, QeT) and kanamycin/furosemide treated animals at
different time points (1wk, EeH; 13wk MeP; 37wk UeX) were co-stained for the presence of the presynaptic ribbon component RIBEYE/CtBP3 and the sensory afferent marker Na,
K-ATPase a3 subunit (NKAa3). In untreated samples, there is clear localisation of the RIBEYE protein at the base of the IHCs (arrows, A’, I’, Q’; apical, basal and mid turns
respectively). This staining is mostly lost 1wk post-treatment (arrow, E’) and has completely gone at later stages (13wk, M’; 37wk, U’). There is a concomitant loss in treated samples
of the nuclear localised RIBEYE protein which is seen in the IHCs of untreated samples (asterisks, A, A’; I, I’; M, M’), indicating a loss of these cells. The OHCs, indicated by brackets in
A, D, I, L, Q, S, are also lost in the treated conditions. The SGN marker NKAa3 is maintained in all samples regardless of time post-treatment (arrowheads B, F, J, N, R, V), further
conﬁrming the residual ‘innervation’ of the organ of Corti months after the loss of the IHCs. Panels A’, E’, I’,M’, Q’ and U’ are magniﬁed insets of the boxed regions in A, E, I, M, Q and
U. Scale bars e 50 mm throughout panels AeX, while 10 mm in panels A’, E’, I’, M’, Q’, U’.
Table 3
Analysis of mean SGN number at each level of the cochlea in treated animals (n ¼ 12) and untreated controls (n ¼ 5). A signiﬁcant loss of SGNs is only seen in the mid-turn of
the cochlea in treated animals. ‘n’ refers to the number of animals counted per condition.
Apical Mid Basal
Cells/mm2 n p < 0.05? Cells/mm2 n p < 0.05? Cells/mm2 n p < 0.05?
Untreated 1839 5 2106 5 2168 5
Treated 1842 12 No 1857 12 Yes** 2124 12 No
L. Abbas, M.N. Rivolta / Hearing Research 325 (2015) 12e26 21insult. e at 10e20wk after treatment, the loss was seen to be
around 12% compared to the untreated situation; this ﬁgure only
increased to approx. 18% at 20wk and beyond. A deeper analysis of
individual animals showed that the reduction in SGN number wasTable 4
Analysis of mean SGN number at each level of the cochlea for each treated time point coh
stages, being evident at 10wk and more noticeable at 20wk post-treatment. ‘n’ refers to
Apical Mid
Cells/mm2 n p < 0.05? Cells/mm2
Untreated 1839 5 n/a 2106
1wk 1834 3 No 2016
10e20wk 1870 5 No 1857
20wkþ 1802 4 No 1730found in only two of the nine later cases studied, being present in
one case in each cohort, despite all individuals having complete
hair cell loss. As such, this may represent aminor variation between
individuals in a population, similar to the variation in SGN lossort. The signiﬁcant variation in the mid-turn counts results from SGN losses at later
the number of animals counted per condition.
Basal
n p < 0.05? Cells/mm2 n p < 0.05?
5 n/a 2168 5 n/a
3 No 2156 3 No
5 Yes* 2104 5 No
4 Yes** 2132 4 No
L. Abbas, M.N. Rivolta / Hearing Research 325 (2015) 12e2622observed after aminoglycoside-induced ototoxicity in the human
(Huizing et al., 1987; Sone et al., 1998).
3.8. The remaining neurons are sensory afferents
To conﬁrm the identity of the remaining ‘knot’ of neural pro-
cesses at the organ of Corti, sections of treated cochleae at a range
of timepoints post-kanamycin/furosemide treatment were stained
for the presence of the sensory afferent marker, Naþ Kþ-ATPase a3
subunit (NKAa3), which is known to be expressed by Type I SGNs,
particularly where these neurons ordinarily contact the hair cells
(McGuirt et al., 1994; McLean et al., 2009). The remaining neurons
were strongly immunoreactive for this marker (Fig. 7), at 1wk
(Fig. 7F, H), 13wk (Fig. 7N, P) and 37wk post-treatment (Fig. 7V, X)
implying that they are maintaining their sensory afferent identity
despite the absence of the hair cells. The loss of the hair cells was
also conﬁrmed by the loss of RIBEYE/CtBP3 staining at the pre-
synaptic ribbon of the IHC (Khimich et al., 2005) e in untreated
samples (Fig. 7A, A’; I, I’; Q, Q’), there were discrete puncta of
RIBEYE/CtBP3 localisation at the basal pole of the IHCs; this was
mostly lost after kanamycin/furosemide treatment (Fig. 7E, E’; M,
M’; U, U’). There was also a loss of the nuclear RIBEYE/CtBP3
staining (Knirsch et al., 2007), when the treated and untreated
conditions are compared (asterisks, Fig. 7A, A’; I, I’; Q, Q’), which
again illustrates the loss of the IHCs in treated animals. Interest-
ingly, a smaller number of positive puncta were present a week
after treatment (arrow, Fig. 7E’) but when the overall cell
morphology and ABR decrement were taken into account (Fig. 7E’),
this probably represented an IHC undergoing degenerative pro-
cesses. A similar pattern was seen at all three axial levels of the
cochlea e apical (Fig. 7AeH), mid (Fig. 7QeX) and basal (Fig. 7IeP).
Comparable results were obtained when samples were co-labelled
for NKAa3 and the sensory afferent marker PARVALBUMIN (Fig. S2)
e the latter is a marker for both neurons and inner hair cells. There
was a stark loss of PARVALBUMIN staining from the IHCs of treated
animals at 1wk (Fig. S2F), 13wk (Fig. S2N) and 37wk (Fig. S2V)
compared with untreated controls (Fig. S2B, J and R); this loss was
equivalent at the apical (Fig. S2AeH), mid (Fig. S2QeX) and basal
(Fig. S2IeP) levels of the cochlea. However, even in the absence of
these cells, the knot of innervation by the sensory afferents
remained as before (arrowheads, Fig. S2).
3.9. Myelination
A key marker of SGN degeneration after aminoglycoside treat-
ment has been the loss of the myelin sheath coating the cell bodies
and their processes, which has been shown for instance in the
guinea pig (Koitchev et al., 1982) and the cat (Leake and Hradek,
1988) Examination of the myelination proﬁle of the SGNs after
long-term damage (Fig. 8) shows that the expression of myelin
basic protein (MBP) remains indistinguishable from the untreated
condition, even in an animal showing mild SGN loss. This suggests
that the SGN proﬁle is stable e the cells remaining at late stages
after hair cell loss are not undergoing degenerative changes such as
demyelination (Hurley et al., 2007; Ylikoski et al., 1974).
4. Discussion
4.1. The gerbil as a ‘one-shot’ model for ototoxicity
Here we present evidence that the Mongolian gerbil is a reliable
model for ototoxic hearing loss in response to combinatorial
treatment with kanamycin and furosemide and that a single dose
regimen is adequate to induce rapid and profound hearing loss
which does not improve over time. This means that this protocolcan be used in conjunction with prior and subsequent surgical in-
terventions, for instance in combination with the application of
ouabain to the round window to create a model of auditory neu-
ropathy; or with the insertion of an electrode to produce a cochlear
implantation model. The efﬁciency of the ‘one-dose’ approach re-
duces the risks associated with chronic aminoglycoside treatment
(for examples, see (Murillo-Cuesta et al., 2010)) and thus is pref-
erable from an animal welfare, ‘3Rs’ perspective.4.2. Gentamicin has little ototoxic effect in this model
As has been seenwith other models such as the mouse (Murillo-
Cuesta et al., 2010), these animals display differential sensitivities
to different aminoglycosides, in that we do not see a substantial
raising of the hearing threshold in response to gentamicin (Fig. 1),
contrasting with the results seen by Sheppard et al. (2004). The
results here do not necessarily conﬂict with the existing data e it
may be that persistent and repeated application of the drug is
required. When examining previous gentamicin usage in the gerbil,
a shift in auditory threshold has been shown to occur after 4 weeks
of daily, systemic injections (Chen et al., 1997), and hair cell loss has
been demonstrated as being more substantial after ﬁve, daily
transtympanic injections (Wanamaker et al., 1998), so whilst being
effective, these methods lack the efﬁciency that was sought in
developing this protocol. The fact that gentamicin does not impair
the electromotile response of isolated gerbil outer hair cells is in
line with the idea that hair cells are less sensitive to gentamicin
damage in this species (Wang et al., 2007). In addition, Suryadevara
et al. (2009) saw only a moderate reduction in cochlear hair cells
(49% of IHCs, 34% of OHCs) twoweeks after gentamicinwas applied
directly to the round window on a ﬁbrin clot to facilitate slow
release of the drug. In the light of this information combined with
our own observations, we did not further pursue the use of
gentamicin as an ototoxic agent in our model.4.3. Use of gelatine sponge as a delivery vehicle
Gelatine sponge (‘Gelfoam’), has been widely used as a method
of sustained, slow drug release and has been used clinically in the
inner ear to ameliorate the symptoms of Meniere's disease
(Silverstein et al., 1999). A substantial loss of cochlear hair cells was
found two weeks after a gentamicin-soaked Gelfoam block was
placed in apposition to the round window membrane (Sheppard
et al., 2004). However, our functional data (Fig. 1) showed no ef-
fect of this when this experimental method was employed in our
system. It may be however, that the polar nature of the gentamicin
in aqueous solutionmay hinder its transit across the roundwindow
membrane; alternatively, the drugmay become concentrated in the
basal turn, affecting only high frequency hearing. We propose the
former to be a more likely hypothesis, since there is no preferential
loss of high frequency hearing in animals treated topically with
gentamicin as assayed by pure tone-induced ABR. It could be
argued, however, that the loss induced occurs at frequencies above
the scope of our testing equipment but the histology of the treated
cochleae shows that the organ of Corti remains intact throughout
the basal turn and hook regions, suggesting that there is no build-
up of the drug in these areas. Indeed, when kanamycin and furo-
semide were jointly applied on a gelatine sponge, a considerable
shift in click ABR threshold was observed (40e50 dB increase; data
not shown) after 2 weeks, and tone ABRs were lost across the fre-
quency spectrum tested (6e38 kHz) in the treated ear, showing
that these drugs could pass through the round window membrane
and were evenly distributed throughout the endolymph. Interest-
ingly, no loss of hearing was found in the untreated, control ear,
Fig. 8. SGNs do not demyelinate in the long-term after kanamycin/furosemide treatment. Untreated (AeD) and a 22wk post-treatment (EeH) sample were examined for the
expression of myelin basic protein (MBP, A, D, E, H) in Rosenthal's canal of the basal turn of the cochlea. Arrows (A, E) point to MBP staining ensheathing the SGNs. Inset boxes in A’,
E’ represent 1.5 digitally magniﬁed images of the corresponding boxed regions in A and E, respectively to show detail of the MBP sheath. There is no difference in expression
apparent in the treated vs. the untreated condition. Counterstaining with neuroﬁlament-200 (NF-200; B, F) showed the presence of nerve ﬁbres in both cases; DAPI is used to
counterstain the cell nuclei (C, D, G, H). Scale bar e 50 mm throughout.
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drugs to the inner ear ﬂuids of the contra-lateral side.4.4. Potentiation of aminoglycoside ototoxicity with a loop diuretic
The use of an aminoglycoside antibiotic in isolation may be
effective in some systems for inducing ototoxic damage, but this
often requires a prolonged dosage regime, with associated side
effects such as systemic toxicity and high mortality alongside what
is frequently a comparativelymild hearing loss (see (Murillo-Cuesta
et al., 2010; Poirrier et al., 2010) and references within for a more
comprehensive treatment of this issue). Consequently, the experi-
mental approach being pursued was altered to include a co-
application of a loop diuretic, drugs which are well known to
potentiate the effect of the antibiotics. For instance, a single sys-
temic dose of kanamycin in the guinea pig had little effect on the
cochlea until animals were also treated with ethacrynic acid,
wherein complete destruction of the hair cells was observed
(Brummett, 1981). We show that a single, systemic dose of kana-
mycin coupled with furosemide is an efﬁcient method of gener-
ating substantial loss in hearing function. Interestingly, there is
little to no effect on hearing when bumetanide is used as a
potentiating agent, evenwhen the drugs are applied topically to the
round window. This was somewhat surprising, given that the
pharmacology of these loop diuretics implies the activity of
bumetanide to be many times greater than furosemide (Brummett
et al., 1981), but may well reﬂect species-speciﬁc sensitivities e the
guinea pig, for example, is more sensitive to ethacrynic acid than
furosemide with respect to aminoglycoside-induced hair cell loss.
We have also gathered preliminary data suggesting that kana-
mycin/furosemide is also effective when applied topically to the
round window on a gelatin sponge, thus allowing for models of
unilateral deafness to be developed.
We propose that all the hearing loss in evidence in our system
arises as a direct result of the drug administration protocol, even in
animals undergoing relatively ‘long-term’ treatment. Age-related
hearing loss is known to occur in the Mongolian gerbil (Henry
et al., 1980; Mills et al., 1990), however the functional loss we
describe here arises rapidly and does not continue to decline overtime, implying that there is no age-related component at play in
our system e although it could be argued that age-related loss
occurs at a time-point beyond the duration of the experiments
conducted here, this is beyond the scope of the work discussed in
this manuscript. Additionally, there is no evidence of choles-
teatoma in our colony, as has been seen by others (Chole et al.,
1981), giving further weight to our proposal that the deafness we
observe is entirely due to the kanamycin/furosemide treatment
paradigm.4.5. Different species respond in different ways to aminoglycosides
There is a wide-range of literature on the use of animal models
for aminoglycoside-induced ototoxicity, surveying the use of
different compounds in conjunction with different diuretics. The
data within the literature is often contradictory e for instance,
Poirrier et al. saw no effect on ABR or hair cell loss upon sustained
treatment with kanamycin in mice (Poirrier et al., 2010) whereas a
high-frequency hearing loss, consistent with concentration of the
kanamycin within the basal turn, was seen in mice by Hirose and
Sato; moreover, Taylor et al. reported a complete abrogation of
OHCs 48 h after the application of kanamycin and bumetanide
(Hirose et al., 2011; Taylor et al., 2008).
Nevertheless, it is generally accepted that mice are less sus-
ceptible to aminoglycoside damage than for instance, guinea pigs e
the former are renowned for requiring a high and frequent (e.g.
every 12 h for 15 days) dosing regimen to induce a highly variable
and often milder ototoxic lesion (see Poirrier et al., 2010 for a
comprehensive covering of this material). In contrast, the
comparative efﬁciency of deafening in the guinea pig has beenwell
established over the past four decades, in a procedure pioneered by
the Brummett group and continued by many others, for instance
van Loon et al (2013) (Brummett et al., 1975; van Loon et al., 2013).
This has led to the guinea pig being proposed as a better model for
ototoxic hearing loss in the human, where aminoglycosides have
historically been found to have unfortunate side-effects on hearing
function (Matz et al., 1965).
It remains open to conjecture as to the differential sensitivity of
our experimental gerbils to gentamicin as compared to those
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destruction of hair cells was achieved. Laboratory gerbils are
maintained in relatively small colonies, so it may be that different
groups of workers have inadvertently selected for differential drug
sensitivities; alternatively, the age of onset of the treatment may be
a contributing factor e gerbils are typically 12 weeks and above
when entering our experimental schedule, whereas an initiating
age of 5e8 weeks was used by the previous authors.
The primary aim of this study was to investigate the behaviour
of the gerbil sensorineural hearing system when challenged with
aminoglycosides e the data here suggests that hair cell loss and
hearing function is not particularly susceptible to gentamicin or
kanamycin in isolation.4.6. The preservation of spiral ganglion neurons is unusual in
commonly used small laboratory mammals
A notable result found in here is the preservation of both type I
and type II spiral ganglion neurons long after the ototoxic lesion has
occurred e animals were followed for over 8 months and no
appreciable loss of neurons was noted, with cell counts at the base
and the apex of the cochlea being equivalent to those in untreated
animals and cell numbers in themid-turn beingmildly reduced in a
couple of animals. This is relatively unusual amongst rodents and
other small mammalian hair cell loss models e both in the chin-
chilla and the guinea pig, secondary degeneration of the SGNs oc-
curs as a rapid consequence of the ototoxic lesion (Kong et al., 2010;
McFadden et al., 2004; Versnel et al., 2007; Webster et al., 1981).
However, the situation described here is very similar to cases which
have been described in human patients with hearing loss. In cases
of long-term gentamicin ototoxicity in the human a bilateral loss of
the organ of Corti was found in both ears, however, SGNs were
found to be largely unaffected (Huizing and de Groot, 1987). Simi-
larly, in a review of the histology of profoundly deaf patients (Nadol,
1997), the samples coming from those with aminoglycoside-
induced toxicity were found to have the highest residual SGN
counts compared with congenital hearing loss. Furthermore, his-
tological analysis of a temporal bone repository showed that loss of
hair cells was not accompanied by a proportional loss of spiral
ganglion neurons in the equivalent, tonotopical regions (Linthicum
and Fayad, 2009). This is in agreement with our ﬁndings for the
gerbil.
The continued presence of nerve ﬁbres within the organ of Corti
months after the hair cells have been lost is an unusual feature in
our model and suggests that the remaining support cells may be
maintaining their identity and their trophic actions on the pe-
ripheral nerve terminals. The ﬁrst sign of retrograde degeneration
of the SGNs has been suggested to be the ‘dying back’ of these ﬁbres
(Dodson and Mohuiddin, 2000) (and references within) e in the
gerbil model we describe here, the peripheral ﬁbres of the Type I
SGNs still form a ‘knot-like’ structure beneath the position of the
destroyed inner hair cells and no retrograde degeneration is
observed. Nor is there a reduction in the myelination of these pe-
ripheral processes, as has been proposed to occur alongside the
neural degeneration post-deafening in the rat, for example (Hurley
et al., 2007). It has been long been proposed that the inner hair cells
give trophic support to the SGNs e for example (Ylikoski et al.,
1974) e and that the presence of remaining support cells has no
bearing on SGN survival (Bichler et al., 1983). However, our data add
weight to the proposal that the support cells are central to SGN
survival (Schuknecht, 1953; Zilberstein et al., 2012), the key new
ﬁnding here being that the peripheral neural processes in the organ
of Corti are maintained even in the presence of so-called ‘ﬂattened’
epithelium.4.7. Support cell morphology
We observe that in some cases, the organ of Corti remains
intact, lacking hair cells, for several months after the drug treat-
ment, whereas in others, the transition to a ﬂat, ‘damage’ epithe-
lium appears to be ongoing, with both of these phenomena having
been reported previously (Oesterle et al., 2009; Sugawara et al.,
2005; Taylor et al., 2012). This raises interesting questions
regarding the identity and differentiation state of these cells.
Although clearly not ‘normal’ in appearance, the perdurance of
their characteristic support cell markers coupled with the
continued presence of SGN innervation at the site of the IHCs
implies that they may still be capable of supplying trophic support
to the system. When hair cells die in mammals, a permanent scar
of ‘ﬂat’ epithelium eventually replaces the organ of Corti (reviewed
in (Raphael et al., 2007)); debate remains in the literature as to
whether the eventual loss of the support cells is a secondary
consequence of hair cell loss, or results from primary entry of the
aminoglycoside into these cells, which has been demonstrated in
some models (Dai et al., 2006; Wang et al., 2009); indeed the
catastrophic and rapid loss of the organ a week after treatment in
the guinea pig has been proposed by Oesterle to result from such
primary damage to the support cells (Oesterle, 2013). This scar
formation of ﬂattened epithelium is thought to allow a certain
degree of repair to the damaged organ and prevent further insult
to any remaining hair cells which would occur if the perilymph
and endolymph were allowed to mix. The triggers for the transi-
tion from ‘damaged’ organ of Corti to ‘ﬂattened’ epithelium are
currently unknown (Oesterle, 2013) and the identity of cells
bringing about the repair is under debate e are they support cells
which de-differentiate from a columnar to a cuboidal epithelium,
or are they a population of sulcus cells which migrate in to replace
dead support cells? The long-term perdurance of support cell
markers such as OCP2 and acetylated aTUBULIN described here
underpins the former proposal and is supported by data from
others, in which the ‘repaired organ of Corti’ has been described
(Oesterle et al., 2009; Sugawara et al., 2005; Taylor et al., 2012).
We do see occasional remnants of hair cell marker expression e
for instance, the trace of ESPIN seen in Fig. 3M. However, the
morphology of these cells is abnormal, and may be ones that are
undergoing phagocytosis by neighbouring support cells or circu-
lating white blood cells to remove them from the damaged
epithelium (Abrashkin et al., 2006; Hirose et al., 2005).5. Conclusions
The ease with which ototoxic lesions may be induced in the
gerbil, as shown here, adds further credence to the use of this an-
imal as an experimental model for hearing research. Moreover,
while cats and primates manifest a similar preservation of the
auditory neurons for a long time post-insult, this is somewhat
unique amongst commonly-used small laboratory animals, and
reﬂects more accurately the human situation, where spiral ganglion
neurons may remain for substantial lengths of time after hair cell
loss. Given the larger costs and deeper ethical conundrums asso-
ciated with experimentation in cats, dogs and primates, the gerbil
offers a reasonable, complementary model system. We are
combining this treatment with the selective ablation of spiral
ganglion neurons using ouabain (Schmiedt et al., 2002), to generate
a ‘double knock-down’ model. This should provide an ideal system
to investigate cochlear implantation using an implantable stimu-
lator (Millard and Shepherd, 2007), together with restoration of
auditory nerve function by the engraftment of transplanted otic
neural progenitors (Chen et al., 2012).
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